The BR1DGE Global Faculty
The BR1DGE program is built in collaboration with specialists in the field of autoimmune type 1 diabetes (T1D) as well as people representing patient advocacy groups and payer organisations. It’s this world-beating faculty that puts the BR1DGE content at the forefront of modern autoimmune T1D research and learnings.
Richard Oram
NIHR Exeter Clinical Research Facility Exeter, UK
.png/jcr:content/Group%203361839%20(1).png)
Anette Ziegler
Technical University of Munich, Munich, Germany
.png/jcr:content/Frame%203868%20(5).png)
Emily K. Sims
Indiana University, Indianapolis, USA
Lucienne Chatenoud
Professor of Immunology, Institut Necker Enfants Malades-INEM, Paris, France
.png/jcr:content/Frame%203868%20(1).png)
Colin Dayan
Professor of Clinical Diabetes and Metabolism Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK
Thomas Danne
Professor of Pediatrics, Hannover Medical School, Germany
Raffaella Buzzetti
Professor of Endocrinology, Sapienza University of Rome, Rome, Italy
Riitta Veijola
Professor of Pediatrics, University of Oulu and Oulu University Hospital, Oulu, Finland
Chantal Mathieu
Katholieke Universiteit Leuven, Belgium
Lars-Åke Söderlund
International Pharmaceutical Federation (FIP), Stockholm, Sweden
Jurgen Vercauteren
Department of Chronic and Metabolic Diseases, KU Leuven, Leuven, Belgium
Bart Torbeyns
European Diabetes Forum (EUDF), Brussels, Belgium